{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:28:05Z","timestamp":1791210485783,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07040382"],"award-info":[{"award-number":["NRF-2018R1D1A1B07040382"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neo.2018.12.005","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T11:56:02Z","timestamp":1547034962000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["MicroRNA-503-5p Inhibits the CD97-Mediated JAK2\/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells"],"prefix":"10.1016","volume":"21","author":[{"given":"Ga Bin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2018.12.005_bb0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1399-0039.1997.tb02897.x","article-title":"Expression characteristics of the human CD97 antigen","volume":"50","author":"Eichler","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.neo.2018.12.005_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tibs.2008.07.005","article-title":"Adhesion-GPCRs: emerging roles for novel receptors","volume":"33","author":"Yona","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neo.2018.12.005_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1309\/A6AB-VF3F-7M88-C0EJ","article-title":"CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas","volume":"118","author":"Aust","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.neo.2018.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/ijo.2013.2075","article-title":"CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers","volume":"43","author":"Safaee","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.neo.2018.12.005_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00384-010-0926-5","article-title":"The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma","volume":"25","author":"Han","year":"2010","journal-title":"Int J Color Dis"},{"key":"10.1016\/j.neo.2018.12.005_bb0030","doi-asserted-by":"crossref","first-page":"53432","DOI":"10.18632\/oncotarget.18515","article-title":"An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2018.12.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011198","article-title":"Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma","volume":"5","author":"Jinawath","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2018.12.005_bb0040","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3892\/ijo.2012.1568","article-title":"STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers","volume":"41","author":"Wang","year":"2012","journal-title":"Int J Oncol"},{"issue":"14","key":"10.1016\/j.neo.2018.12.005_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2407-14-317","article-title":"Inhibition of the JAK2\/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden","volume":"6","author":"Abubaker","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0050","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.22293","article-title":"The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis","volume":"107","author":"Rosen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas","volume":"100","author":"Colomiere","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neo.2018.12.005_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/cb400704n","article-title":"Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126","volume":"9","author":"Lu","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.neo.2018.12.005_bb0080","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.3748\/wjg.v21.i20.6215","article-title":"CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.neo.2018.12.005_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13048-015-0162-2","article-title":"MicroRNAs in ovarian function and disorders","volume":"8","author":"Li","year":"2015","journal-title":"J Ovarian Res"},{"issue":"1\u20132","key":"10.1016\/j.neo.2018.12.005_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2009.09.021","article-title":"The regulatory role of Dicer in folliculogenesis in mice","volume":"315","author":"Lei","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neo.2018.12.005_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1757-2215-6-18","article-title":"MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance","volume":"6","author":"Park","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.neo.2018.12.005_bb0100","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2018.12.005_bb0105","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.12.005_bb0110","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2009.289","article-title":"TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer","volume":"28","author":"Szajnik","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2018.12.005_bb0115","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3892\/or.2017.5533","article-title":"Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells","volume":"37","author":"Park","year":"2017","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.neo.2018.12.005_bb0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2018.12.005_bb0130","article-title":"Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2018.12.005_bb0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/IJWH.S7012","article-title":"Clinical trials and progress with paclitaxel in ovarian cancer","volume":"2","author":"Kumar","year":"2010","journal-title":"Int J Women's Health"},{"key":"10.1016\/j.neo.2018.12.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694319","article-title":"Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma","volume":"39","author":"Meng","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.neo.2018.12.005_bb0145","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ijc.20483","article-title":"N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding","volume":"112","author":"Wobus","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2018.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.2353\/ajpath.2006.060006","article-title":"Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion","volume":"169","author":"Galle","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neo.2018.12.005_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.neo.2018.12.005_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-61779-037-9_3","article-title":"Viral miRNAs","volume":"721","author":"Plaisance-Bonstaff","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neo.2018.12.005_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.952325","article-title":"Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia","volume":"123","author":"Caporali","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.neo.2018.12.005_bb0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.01.028","article-title":"MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth","volume":"333","author":"Zhou","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2018.12.005_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jso.21941","article-title":"Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell","volume":"104","author":"Zhou","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.neo.2018.12.005_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/OTT.S114303","article-title":"Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker","volume":"10","author":"Wu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.neo.2018.12.005_bb0185","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1159\/000373972","article-title":"Enhancement of LPS-induced microglial inflammation response via TLR4 under high glucose conditions","volume":"35","author":"Zhang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.neo.2018.12.005_bb0190","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2018.12.005_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2014.00075","article-title":"Targeted Disruption of the JAK2\/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden","volume":"4","author":"Abubaker","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.neo.2018.12.005_bb0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"Ahmed","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.neo.2018.12.005_bb0205","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-14-0607","article-title":"CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis","volume":"14","author":"Burgos-Ojeda","year":"2015","journal-title":"Mol Cancer Ther"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558618305104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558618305104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:04:59Z","timestamp":1761483899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558618305104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1476558618305104"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2018.12.005","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-503-5p Inhibits the CD97-Mediated JAK2\/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}